HT29 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF732
Target Cell Organism: Human
Target Cell Alternative Name: HT-29
Target Cell Name: HT29
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide HT29-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HT29
Target Cell Organism
Human
Target Cell Background
HT-29 is a cell line from a White, female colorectal adenocarcinoma patient that can be used in cancer and toxicology research.
Target Cell Alternative Name
HT-29
Related Diseases
Colorectal Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
HT29-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry